| T Titan Pharmaceuticals, Inc.
87278810 22 Dec 2016 | on 10 Sep 2019
| Pharmaceuticals, namely, treatment for central nervous disorders, canc... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized letter "T" with the top left half in the color red, forming the left edge of a triangle that is red with a dot in the middle in the color white and that includes within it the top right and bottom of the letter "T" in white. | | | T TITAN PHARMACEUTICALS Titan Pharmaceuticals, Inc.
87278812 22 Dec 2016 | on 18 Jun 2019
| Pharmaceuticals, namely, treatment for central nervous disorders, canc... Class 005 Class 005 Pharmaceutical Products "PHARMACEUTICALS" | | | TITAN PHARMACEUTICALS Titan Pharmaceuticals, Inc.
87457505 19 May 2017 | on 09 Sep 2024
| Pharmaceuticals, namely, treatment for central nervous disorders, canc... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases | | | PROBUPHINE Titan Pharmaceuticals, Inc.
86356901 04 Aug 2014 | on 13 Oct 2023 | Pharmaceuticals, namely, implantable drug delivery system comprised pr... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | PROBUPHINE Titan Pharmaceuticals, Inc.
85867659 05 Mar 2013 | on 06 Oct 2023 | Pharmaceuticals, namely, implantable drug delivery system comprised pr... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | BUPEPLANT Titan Pharmaceuticals, Inc.
88427943 13 May 2019 | on 12 Apr 2021 | Pharmaceuticals, namely, implantable drug delivery system comprised pr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases | | | STEP INTO STABILITY Titan Pharmaceuticals, Inc.
88355910 25 Mar 2019 | on 12 Apr 2021 | Pharmaceuticals, namely, implantable drug delivery system comprised pr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases | | | BUPLANT Titan Pharmaceuticals, Inc.
87009766 21 Apr 2016 | on 09 Dec 2019 | Pharmaceuticals, namely, implantable drug delivery system comprised pr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases | | | T Titan Pharmaceuticals, Inc.
86328553 03 Jul 2014 | on 23 Jan 2017 | Pharmaceuticals, namely, treatment for central nervous disorders, canc... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized letter "T", a triangle with a dot in the middle and an incomplete square. | | | PROBUFAN Titan Pharmaceuticals, Inc.
85825831 17 Jan 2013 | on 19 Sep 2016 | Pharmaceuticals, namely, implantable drug delivery system comprised pr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases | | 
